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Abstract
Sudden infant death syndrome (SIDS) is the leading cause of death in infants between the ages of 1 and 12 months in
developed countries. SIDS is by deﬁnition a diagnosis of exclusion, and its mechanism of action is unknown. The SIDS–
Critical Diaphragm Failure (CDF) hypothesis postulates that the cause of death in SIDS is respiratory failure caused by CDF.
Four principal risk factors contribute to CDF in young infants: undeveloped respiratory muscles, non-lethal infections, prone
resting position, and REM sleep. Even relatively minor infections can cause an acute and signiﬁcant reduction in diaphragm
force generation capacity that in conjunction with other risk factors can precipitate CDF. CDF-induced acute muscle weakness
leaves few, if any pathological marks on the affected tissue.Understanding the underlying mechanism of SIDS may help in
formulating new approaches to child care that can help to further reduce the incidence of SIDS.
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Introduction
It has been recognized since antiquity that seemingly
healthy infants can die suddenly and for no obvious
reason during their sleep. Indeed, the Bible makes
reference to such an incidence in the First Book of
Kings. One of the ﬁrst known medical autopsies of
an apparent sudden infant death syndrome (SIDS)
case was conducted by Samuel Fearn and published
in the Lancet in 1834 (1). In his short communica-
tion, Fearn asked a simple question that has frus-
trated generations of doctors and researchers: ‘what
was the cause of death?’ Over 175 years later the
question is still unanswered (2). SIDS has been the
target of an enormous research effort, with over
9,500 scientiﬁc articles published on the subject
(3), but it remains one of the most mysterious
disorders in medicine.
Our primary research interest, cancer cachexia (4),
gave us a singular perspective into SIDS, and we
formulated the SIDS–Critical Diaphragm Failure
( C D F )h y p o t h e s i st oa n s w e rF e a r n ’so r i g i n a lq u e s -
tion. It is perhaps surprising that research areas
unrelated to SIDS could contribute meaningfully
to the understanding of this complex syndrome,
and yet there is a large body of experimental and
clinical evidence that suggests that the cause of
death in SIDS is respiratory failure caused by
CDF. We argue that four factors contribute to
CDF in SIDS: undeveloped respiratory muscles,
non-lethal infections, prone resting position, and
REM sleep. Infants younger than 6 months have
undeveloped respiratory muscles that are susceptible
to CDF, because even minor infections can precip-
itate a signiﬁcant reduction in the diaphragm force
generation capacity. The prone sleeping position
signiﬁcantly increases the diaphragm work-load,
and the intercostal muscles that usually provide
respiratory support are inactivated in REM sleep.
The non-monotonic mortality rate of SIDS is
explained by the passive maternal antibodies that
effectively attenuate infections during the ﬁrst month
of life, and rapid development of the infant dia-
phragm that reaches the same ﬁber composition
and pressure generation capacity as the adult muscle
approximately 6 months post partum.
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Research has identiﬁed over 40 potential SIDS risk
factors (5), making the investigation of the syndrome
extremely complicated. However, the salient and
uncontentious characteristics of SIDS are well
known; it affects fewer than 1 in 1000 live births in
the developed world and is associated with sleep, a
bell-shaped mortality incidence rate (peak age 2–4
months), premature and low-birth-weight infants,
male gender (60% of cases), episodes of non-lethal
infections, and the prone sleeping position (6–8). So
far, no convincing genetic or congenital mechanism
for SIDS has been identiﬁed.
SIDS is by deﬁnition a diagnosis of exclusion that
has no identiﬁable cause of death. However, it is
generally accepted that sudden death that is not
caused by trauma must be due to either respiratory
or circulatory failure (9). Clinical observations, heart-
rate, and respiratory recording of infants who subse-
quently succumb to SIDS and animal models strongly
suggest a respiratory pathway for the syndrome (2).
The absence of any obvious defects or abnormalities
in the lungs or inspiratory muscles has led to the
conclusion that respiratory failure in SIDS must be
caused either by a dysfunctional control system (2,10)
or upper airway obstruction (11). However, the dys-
functional respiratory control system hypothesis fails
to explain many of the salient features of SIDS (6),
and studies have found no signiﬁcant respiratory
abnormalities in infants who subsequently die of
SIDS (12,13). Furthermore, both human and animal
studies (14–17) suggest that upper airway occlusion is
not a precipitating factor in SIDS, and obstructive
apnea as the cause of SIDS is arguably doubtful.
The respiratory failure hypothesis is still favored by
many SIDS researchers (11), but so far no convincing
mechanism has been identiﬁed. Surprisingly, the
possible role of the diaphragm in the etiology of
SIDS has been largely ignored. In October 2010,
there were only 41 PubMed hits with the search
words ‘SIDS and diaphragm’ from a total of over
9,500 SIDS articles (18). Yet, the diaphragm is the
main respiratory muscle, and as Muller and Bryan
observe ‘respiratory failure is frequently respiratory
muscle failure’ (19).
Diaphragm and survival
Two muscles are essential for human survival, and
while the vital role of the heart is obvious, the dia-
phragm is often overlooked. The diaphragm is a thin
muscle that is shaped like a parachute and that sepa-
rates the thoracic from the abdominal cavity. It is the
main engine of the vital respiratory pump (20), and
its contraction is critical for intrathoracic pressure
generation (21). Anraku and Shargall note that ‘in
adults, the diaphragm represents less than 0.5% of
body-weight, but it is the most important muscle in
the human body after the heart’. The incapacitation of
supportive respiratory muscles, such as the intercos-
tals, is not lethal, but bilateral diaphragm paralysis
usually results in respiratory failure (22). The adult
diaphragm can generate indeﬁnitely approximately
40% of its maximum transdiaphragmatic pressure
(Pdimax) (23), but it is susceptible to critical fatigue
in certain conditions. Macklem succinctly observes
that ‘the inspiratory muscles form a pump just as vital
as the heart, and this pump can and does fail in much
the same manner as the heart fails’ (20). In adults,
respiratory muscle weakness is one of the most com-
mon causes of ventilatory failure (24).
We argue that the diaphragm is the locus minoris
resistentiae in SIDS. The young infant has undevel-
oped secondary respiratory muscles, and the dia-
phragm is responsible for the majority of respiratory
work (25). Assuming the same relative organ propor-
tions as in the adult, a normal neonate weighing
3000 g would have a diaphragm that weighs approx-
imately 12 g and is approximately 2 mm thick (26).
Indeed, roughly similar dimensions are observed in
preterm infants weighing between 1260 g and 2100 g
who have diaphragms that are between 1.09 (±0.08)
and 1.74 (±0.04) mm thick (27). An increase in
diaphragm size correlates directly with inspiratory
force (28), and full-term infants reach adult levels
of Pdimax at approximately 6 months of age (25). The
diaphragm in young infants is also structurally imma-
ture and signiﬁcantly more susceptible to fatigue than
a fully developed muscle. A premature infant’s dia-
phragm consists of only 10%fatigue-resistant type I
ﬁbers. The diaphragm of a full-term infant has 25%
type I ﬁbers, increasing to 40% at 3 months and to
50%–55% (adult share) (22) by the age of 7–8 months
(19).The younger the infant, the smaller the oxidative
capacity of the respiratory muscles and the higher the
risk for ventilatory muscle fatigue (19). We suggest
this may be a reason why low-birth-weight or prema-
ture infants have up to four times the risk of SIDS
compared to full-term neonates (8). Overall, the
respiratory muscles of the young infant appear to
be poorly equipped to sustain increased work-loads.
Muller and colleagues argue that ‘the normal preterm
and term infant is very close to the threshold of
diaphragmatic fatigue’ (29). Indeed, fatigue patterns
can readily be observed if the work of breathing is
increased in young infants (30). Still, some authors
have suggested that the infant diaphragm is not at
increased risk of fatigue and that it may be even more
fatigue-resistant than the adult inspiratory muscle
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ported by the existing evidence. However, even those
who disagree about the relative fatigue risk of the
infant diaphragm agreed that it can and does fatigue
under certain conditions.
Infection-induced acute diaphragm weakness
The central argument of the SIDS–CDF hypothesis is
that even minor infections can cause a rapid and
signiﬁcant reduction in diaphragm strength. Respira-
tory muscle performance can decline for two reasons:
due to a reduction in total muscle mass or due to a
decline in muscle force generation capacity (32). The
loss of muscle mass is an incremental process and is
usually associated with chronic diseases such as cancer.
The reduction of force generation capacity is associ-
ated with acute conditions such as sepsis where muscle
strength can decline signiﬁcantly within hours. We
propose that an acute decline in muscle force-
generating capacity is primarily responsible for CDF
in SIDS cases. A large body of evidence strongly
suggests that various types of infections, both viral
and bacterial, can cause a signiﬁcant and acute reduc-
tion in diaphragm force-generating capacity. Impor-
tantly, even minor infections can signiﬁcantly reduce
diaphragm strength without affecting muscle mass or
histology.
Acute infections were shown to reduce signiﬁcantly
skeletal muscle strength in 1977 (33). Since then,
numerous human and animal studies have shown
that infections can induce severe diaphragm and
secondary respiratory muscle weakness (34,35),
whereas the cardiac muscle does not appear to be
similarly vulnerable (36). Standardized endotoxins
are often used to study diaphragm force reduction
(37–39), but a broad range of pathogens, both viral
and bacterial, has a similar effect. Human studies and
animal models have shown that signiﬁcant diaphragm
weakness can be induced by endotoxin injection (40),
bronchopulmonary infection (41), septic peritonitis
(42), parasitic infection (43), and pathogens such as
Escherichia coli (44), group B Streptococcus (45),
Streptococcus pneumoniae (S) (46), Pseudomonas aeru-
ginosa (41), Bordetella pertussis (47), Phlebovirus (48),
as well as factors associated with upper respiratory
tract infection (49). A case study of an infant with
vulnerable respiratory muscles illustrates the point.
The patient exhibited diaphragm muscle dystrophy as
the sole anomaly and suffered from episodes of severe
respiratory distress that required mechanical ventila-
tion to sustain life (50). Interestingly, these episodes
occurred only during Staphylococcus aureus or Haemo-
philus inﬂuenzae infections. The evidence cited above
strongly suggests that various pathogens, both viral
and bacterial in origin, can precipitate a signiﬁcant
reduction in the ventilatory capacity of the diaphragm.
It is well known that systemic infection can lead to
severe loss of diaphragm strength and respiratory fail-
ure (51). However,also less severeinfections can cause
as i g n i ﬁcant reduction in the force-generating capacity
of the diaphragm. Animal studies have shown that
non-lethal sepsis induced by either Streptococcus pneu-
moniae or E. coli with no change in blood pressure,
serum electrolytes, or acid status caused a signiﬁcant
impairment of diaphragm function (52). In human
adults, Mier-Jedrzejowicz and co-workers observed
already in 1988 that pulmonary function can deterio-
rate signiﬁcantly (P < 0.05) after even apparently mild
respiratory infections (53). In patients with vulnerable
respiratory systems, routine infections have been
shown to result in shortness of breath, reduction in
vital capacity, and acute hypercapnia (49). Supinski
and colleagues recently concluded that in vulnerable
populations, ‘increasing evidence indicates that even
minor infections can produce profound reductions in
diaphragmatic force-generating capacity’ (54). A large
body of experimental evidence supports this observa-
tion (34,41,43,55–58). It is important to note that the
degree of diaphragmatic force reduction is determined
not only by the intensity of the infectious assault but
also by the immune and the developmental status of
the host (41,45). Fundamentally, terms such as ‘lethal’
or ‘minor’ used to characterize infections are always
relative.
Infectionscanreducetheforce-generatingcapacityof
the diaphragm by 50% in as little as 24 hours (54), and
leadtosevererespiratorymuscledysfunctionandrespi-
ratory failure (45). In a study on human adults with
routine upper respiratory tract infection, diaphragm
strength fell signiﬁcantly (P < 0.01), with the largest
declineoccurringbetweendays3and7ofclinicalillness
(53). Fullrecoveryofrespiratorypressuretookplaceby
day 14. Numerous other studies show that a signiﬁcant
reduction in diaphragm strength can occur within 1 to
48 h of infection indicating that a signiﬁcant decline in
the performance of the main respiratory muscle can
occur very rapidly (34,41,42,49,51,59). However,
infection-induced muscle force reduction is an acute
buttemporaryevent,andthediaphragm can recoverits
normal function relatively quickly. This may explain
why near-SIDS cases do not manifest diaphragmatic
weakness (60).
Animal models using either Streptococcus pneumo-
niae or E. coli endotoxin show that non-lethal sepsis
impairs diaphragm function without affecting muscle
mass or histology (46,61). Supinski and Callahan
have observed that ‘24 h after administration of endo-
toxin, diaphragm speciﬁc force had fallen by 50%
without any reduction in diaphragm muscle mass
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major diaphragm protein bands or speciﬁc loss of
myosin or actin stores’ (57). Sepsis reduces muscle
strength long before contractile protein levels decline
signiﬁcantly (34). Others have reported similar results
(62,63), conﬁrming that even though infections can
cause acute and severe diaphragm dysfunction, they
leave few, if any pathological marks in the affected
tissue. These ﬁndings are of some importance,
because the absence of signiﬁcant pathophysiological
abnormalities in the inspiratory musculature of SIDS
cases has led to the erroneous conclusion that the
diaphragm does not play a role in the etiology of the
syndrome (10).
The one pathological ﬁnding that characterizes over
70% of SIDS cases is intrathoracic petechiae (64).
Goldwater reported recently that SIDS cases demon-
strate intrathoracic petechial hemorrhages in the thy-
mus (89.5%), pleura (80%), and epicardium (79.9%)
(16). SIDS-related intrathoracic petechiae are not
characteristic of asphyxia, strangulation (16), upper
airway obstruction (17), or cardiac arrest (64).
Rather, experimental evidence suggests that an infec-
tion together with gasping or a ‘struggle to breathe’
episode is required for the formation of characteristic
intrathoracic petechial hemorrhages (17,65). Interest-
ingly, the clinical signs of respiratory muscle fatigue
are rapid shallow breathing, paradoxic chest wall/
abdominal movements, and respiratory pauses com-
bined with hyperventilation (20,66).
The data presented above strongly suggest that
even minor infections can cause a signiﬁcant and
rapid reduction in diaphragm force-generating
capacity without affecting muscle mass or histology.
Surprisingly, the pathophysiological implications of
infection-induced acute diaphragmatic weakness have
not been previously considered in the context of SIDS
even though it is well known that young infants have
undeveloped and potentially vulnerable respiratory
muscles.
Mitochondrial dysfunction and the role of
melatonin in SIDS
The molecular mechanisms behind infection-induced
acute diaphragm weakness have been actively investi-
gated. Systemic infection displays consistent similari-
ties to the pathogenesis of SIDS (67), and can induce a
signiﬁcant (P < 0.001) reduction in the mitochondrial
function (e.g. ATP-generating capacity) of the dia-
phragm muscle tissue (68). There is substantial evi-
dence that excessive free-radical generation plays a
central role in infection-induced myopathy and causes
mitochondrial impairment. Infection causes signiﬁcant
changes in oxidative phosphorylation and induces the
selective depletion of several electron transport chains
in the respiratory muscles (32). Newborns and infants
born prematurely are especially prone to oxidative
stress because they are exposed to high oxygen con-
centrations and have reduced antioxidant defense
mechanisms and high levels of free iron that are
required for the Fenton reaction (69). Existing evi-
dence strongly suggests that infections can produce
rapid and profound alterations in the mitochondrial
function of the diaphragm and severely disrupt its
energy metabolism.
Melatonin (N-acetyl-5-methoxytryptamine) is a
highly conserved small amphiphilic molecule that is
biosynthesizedfromtryptophan.Serotoninisconverted
to melatonin in the pineal gland by arylalkylamine
N-acetyltransferase (AA-NAT) and hydroxyindole
O-methyltransferase (HIOMT) (70). Serotonin is a
rate-limiting factor for melatonin. Melatonin has been
shown to protect against oxidative stress in various
divergentexperimentalsystems(71).Itisahighlyeffec-
tive antioxidant and free-radical scavenger that can
signiﬁcantly attenuate mitochondrial failure and pre-
serve cell function and survival (72–74). In the clinical
setting, melatonin has been shown to improve the clin-
ical outcome in the septic newborn (75). Gitto and
colleagues observe that ‘several clinical studies that
used melatonin showed that it reduces oxidative stress
in newborns with sepsis, distress or other conditions
where there is excessive ROS/RNS (reactive oxygen
species/reactive nitrogen species) production’(69).
However, young infants exhibit transient melatonin
deﬁciency for the ﬁrst 2–4 months of life (76).
Pineal dysfunction and impaired melatonin metab-
olism have been associated with SIDS (77,78). Sturner
and colleagues examined melatonin levels from
the ventricular cerebrospinal ﬂuid (CSF) in SIDS
deaths compared to non-SIDS cases. After adjusting
for age differences, melatonin levels were signiﬁ-
cantly (P < 0.05) lower among the SIDS infants
(91 ± 29 pmol/L; n = 32) than among those dying
of other causes (180 ± 27; n = 35) (79). Young infants
who experienced a life-threatening event (ALTE)
demonstrated signiﬁcantly (P < 0.05) lower uri-
nary excretion of the main melatonin metabolite
6-sulfatoxymelatonin compared to controls (1588
ng/24 h versus 3961 ng/24 h) (80). Serotonergic deﬁ-
ciency has repeatedly been associated with SIDS (81),
suggesting that the role of the tryptophan–serotonin–
melatonin pathway in the etiology of SIDS should be
further investigated.
The prone sleeping position and SIDS
A change in the recommended sleeping position for
young infants from prone to supine has reduced
118 P. M. A. Siren & M. J. SirenSIDS deaths worldwide between 40% (Argentina)
and 83% (Ireland) (2). SIDS can occur in the supine
resting position, but any hypothesis regarding the
etiology of SIDS must convincingly explain why the
prone sleeping position is such a signiﬁcant risk
factor.
The effects of the prone sleeping position on
diaphragm function have been considered previously
(82). The hypothesis that the prone sleeping position
signiﬁcantly increases the work-load of the dia-
phragm was tested by Rehan and co-workers in a
study with 16 healthy infants (83). The study showed
that in the prone position the diaphragm is signiﬁ-
cantly thicker and, therefore, shorter at the end of
both expiratory (EEV) and inspiratory lung volumes
(EIV). The shortening of any muscle produces a
marked fall in the maximal tension it can develop
(19), indicating that the inspiratory muscle force of
the diaphragm decreases as it shortens. Indeed,
Rehan and colleagues note that ‘this degree of dia-
phragm shortening is similar to that seen with an
increase in lung volume of 15%–30% of vital
capacity’. Such increases in EEV can signiﬁcantly
impair diaphragm performance, and, as Rehan and
colleagues conclude, ‘in adults, diaphragm strength
and endurance as well as the efﬁciency of breathing
are reduced by 40%–50% with this magnitude of
increase in lung volume’. Greenough and colleagues
have reported similar results in several clinical
studies with premature infants and observe that
respiratory muscle strength is signiﬁcantly reduced
in the prone compared to the supine position in
(106–108).
Interestingly, an earlier study that measured infant
breathing did not ﬁnd signiﬁcant differences in ven-
tilatory performance as a function of sleep position
(84). However, the study reported a signiﬁcant
increase (+66%) in rib-cage motion in the prone
compared with the supine position. Others have
observed that due to the high rib-cage compliance
in young infants, the thorax motion increases either
during deep inspiratory effort or when the intercostals
are inactivated (31). As both the sleep position studies
were conducted during non-REM (NREM) sleep
when the intercostals are active, it is possible that
the signiﬁcantly increased thoracic motion in the
prone position was due to increased diaphragm
work needed to maintain ventilation pressure at the
same level as in the supine position. Indeed, in
another study with healthy infants sleeping in the
prone position, chest wall distortion during REM
sleep led to the reduction of the tidal volume, but
ventilation was upheld by signiﬁcantly (P < 0.01)
increasing the work-load of the diaphragm (85). We
suggest that healthy infants with normal diaphragms
can easily tolerate the added mechanical strain that
the prone position imposes on the diaphragm. How-
ever, for some infants the prone sleeping position
combined with an infectious episode can increase
the risk of CDF.
Why is SIDS associated with sleep?
SIDS deaths often take place between midnight and
6 a.m. (5,86), and there is a close temporal relation-
ship between SIDS and sleep (87). The original name
for SIDS, ‘cot death’,r e ﬂects this basic observation.
The reason for the preponderance of SIDS deaths
during sleep is unclear, and while we should remem-
ber that newborns sleep up to 20 hours per day, there
seems to be a causal link between sleep and SIDS. A
premature infant spends up to 80% and a 3-month-
old approximately 38% of his sleep in the REM phase
(19). It is well known that the intercostals muscles
show both phasic and tonic inhibition during REM
sleep that renders them largely or totally inactive, and
that this has a signiﬁcant effect on respiratory function
(31,88–90). The intercostals play a central role in
stabilizing the thorax, and, as Davis and Bureau
note, ‘chest wall muscles are critical for ventilation
in the infant with a pliable chest wall’ (66). Others
have suggested that the inactivation of the intercostals
during REM sleep may be a contributing factor in
SIDS (82). We argue that the inactivation of the
intercostal muscles in combination with other factors
can increase the risk of CDF.
The internal and external intercostal muscles are
activated to attenuate diaphragm fatigue (19,91,92).
In a study with preterm infants, diaphragm fatigue
was followed either by a 50%–150% increase in inter-
costal activity or apnea that lasted 10–30 s and often
required stimulation (93). In full-term infants, dia-
phragm fatigue provokes similar responses: the inter-
costal muscles are activated to support the respiratory
effort or apnea lasting 5–20 s ensues (followed by
intercostal muscle activation) (91). In another study,
the diaphragmatic work-load in the young infant
increased by over 150% (P < 0.001) during REM
sleep (29). Diaphragmatic fatigue patterns were
observed only in REM sleep together with marked
reductions in intercostal activity and rib-cage retrac-
tion. In the young infant intercostal muscle support is
even more important than in the adult because their
rib-cage is mostly cartilaginous and signiﬁcantly more
compliant compared to adults. If the intercostals do
not stabilize the rib-cage during inspiration, a signif-
icant portion ofthepowergenerated by the diaphragm
will be wasted sucking in the ribs rather than fresh air
(94), and to maintain the same tidal volume the work
of the diaphragm has to increase substantially (88).
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to diaphragm fatigue.
The studies discussed above suggest that REM
sleep is associated with increased diaphragmatic
work-load and respiratory muscle fatigue in normal
infants. Importantly, a fatigued diaphragm can be
relieved only by decreasing the respiratory work-
load or by activating the intercostals. If the critically
fatigued muscle is not supported by the secondary
respiratory muscles, ventilatory efﬁciency and muscle
oxygenation will progressively decline and the risk of
respiratory failure increases.
The bell-shaped mortality rate in SIDS
One of the more puzzling aspects of SIDS is the
bell-shaped mortality incidence rate. SIDS seems
closely related to the developmental status of the
infant, because 95% of the cases occur before the
age of 6 months, and SIDS is rare in infants 1 year
and older. Paradoxically, SIDS is also rare in infants
younger than 1 month (5). SIDS clearly has a differ-
ent type of mortality incidence rate compared to the
monotonic distribution in congenital anomalies (6).
Others have argued that bacterial toxins cause SIDS
and that maternal antibodies can protect the infant
during the ﬁrst months of life (95). We suggest that
the bell-shaped mortality distribution of SIDS is due
to the passive immune protection maternal antibodies
provide during the ﬁrst month of life when the respi-
ratory muscles are most vulnerable.
The age proﬁle of SIDS deaths is reciprocal to
infants’ serum concentrations of immunoglobulin
(96), and maternal antibodies can increase the
immune resistance of neonates during the ﬁrst
months of life (97,98). Infants have varying levels
of passive immune protection because the maternal
antibody concentration determines the neonatal titer
at birth (99). Full-term infants seem to have higher
antibody titers than premature ones (100). However,
the passive immune protection wanes relatively rap-
idly in all neonates. A study with 213 mother–infant
pairs showed that the mean time to immunity loss for
rubella and varicella was 2.1 months and 2.4 months,
respectively (101). For measles the maternal antibo-
dies endured for a median of 2.6 months (99). Mater-
nal antibodies to the Varicellazoster virus (VZV) had
a median half-life of 25.5 days in neonates (range
14.6–76.0 days) (102). Another study showed that
26% of infants had potentially protective antibody
levels against pertussis (whooping cough) at delivery,
but by week 6 nearly 90% had lost most of the original
maternal antibodies (103). These and other studies
(104,105) suggest that neonates can beneﬁt from
passive maternal immune factors for 1–2 months
post partum but that the temporary immune protection
wanes relatively quickly.
Concluding remarks
We propose that the cause of death in SIDS is
respiratory failure caused by CDF. It is well known
that young infants have potentially vulnerable dia-
phragms and that infections can produce severe respi-
ratory muscle dysfunction. We argue that ‘non-lethal’
infections are the main cause of CDF in SIDS. As
such, there is no speciﬁc underlying genetic or con-
genital vulnerability in SIDS infants, and completely
normal infants can die of SIDS. However, infants with
weak or underdeveloped respiratory muscles who
spend a large portion of the day in REM sleep and
are exposed to infections are at increased risk. Dys-
functional melatonin metabolism may also be a con-
tributing factor in SIDS. By deﬁnition, the infections
associated with SIDS are not considered to be lethal,
but they can cause a signiﬁcant and acute loss of
diaphragm strength. Additional stressors such as
the prone sleeping position and REM sleep can
move the infant closer to CDF and precipitate respi-
ratory failure. Diagnosing CDF-precipitated respira-
tory failure is challenging because it usually does not
affect muscle mass or histology.
An obvious question that the SIDS–CDF hypoth-
esis might raise is that if young infants have vulnerable
respiratory muscles and even minor infections can
cause signiﬁcant loss of diaphragm strength, why is
SIDS not more common? Diaphragm fatigue is not
the same as diaphragm failure, and while young
infants are susceptible to CDF, they also have effec-
tive defense mechanisms that help preserve respira-
tory function. First, the immune system actively
attenuates the negative effects of infectious assaults.
Second, the activation of the intercostal muscles
can decrease the respiratory burden and support a
fatigued diaphragm. Third, the diaphragm develops
rapidly, and by age 6 months has the same distribu-
tion of fatigue-resistant ﬁbers and pressure-generating
capacity as the adult muscle. Thus, moving from
diaphragm fatigue to CDF usually requires a relatively
rare combination of events that include an infectious
episode, insufﬁcient immune response, undeveloped
respiratory muscles, continuous REM sleep, and
often a prone resting position. Even if all these factors
are present, the fatigued diaphragm may be rescued
by altering the sleep state and activating the secondary
respiratory muscles.
The clinical impact of an infection is dependent on
its intensity as well as the immune and developmental
status of the host. A potent infection can alone be
lethal to a young infant, but a less severe infection will
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Yet, diagnosing an apparently ‘non-lethal’ infection as
the cause of death is by deﬁnition a contradiction in
terms. In a sense, a SIDS diagnosis reﬂects the failure
to understand that apparently ‘minor’ infections can
be fatal to some infants in certain circumstances. If the
causes of infant mortality can be accurately ascribed,
SIDS may no longer be needed as a diagnosis.This
goal should be pursued in the spirit of Fearn’s original
question.
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